NDC 68180-984
budesonide inhalation
Budesonide Inhalation
budesonide inhalation is a Respiratory (inhalation) Suspension in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Budesonide.
| Product ID | 68180-984_0976f1d7-c5a8-4d08-a96b-4ea17ddf5ace |
| NDC | 68180-984 |
| Product Type | Human Prescription Drug |
| Proprietary Name | budesonide inhalation |
| Generic Name | Budesonide Inhalation |
| Dosage Form | Suspension |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2019-05-21 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA210897 |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Substance Name | BUDESONIDE |
| Active Ingredient Strength | 1 mg/2mL |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |